Literature DB >> 28262004

Update on the cytologic features of papillary thyroid carcinoma variants.

Marc Pusztaszeri1, Manon Auger2.   

Abstract

Papillary thyroid cancer (PTC), which accounts for 85-90% of all thyroid cancers, is generally an indolent tumor with long term survival rates >95%. A reliable definitive diagnosis of PTC is usually straightforward in fine needle aspirates of conventional PTC whenever the characteristic papillary and/or flat honeycomb sheet-like architecture and the typical nuclear features of chromatin pallor, nuclear enlargement, crowding, grooves and pseudoinclusions are encountered. Conventional PTC, however, has diminished in relative frequency as compared to PTC variants, especially the noninvasive follicular variant of PTC, an indolent tumor which has recently been reclassified as "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" (NIFTP). These PTC variants are characterized by various architecture, cell type and shape, and stromal features, some of which can be recognized cytologically. Awareness of the cytomorphological spectrum and of the characteristic cytological features of these PTC variants is important to avoid diagnostic pitfalls. In this article, we review the different variants of PTC, including their cytomorphologic features, differential diagnosis, and salient molecular features. Diagn. Cytopathol. 2017;45:714-730.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  NIFTP; cytology; molecular; papillary thyroid carcinoma; thyroid; variant

Mesh:

Year:  2017        PMID: 28262004     DOI: 10.1002/dc.23703

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  9 in total

1.  Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions.

Authors:  Qihao Sun; Hongjian Zhao; Zhiyong Liu; Fengqian Wang; Qian He; Cheng Xiu; Lunhua Guo; Qiushi Tian; Lijun Fan; Ji Sun; Dianjun Sun
Journal:  Endocrine       Date:  2021-06-02       Impact factor: 3.633

2.  Cytomorphologic features as predictors of aggressiveness in patients with pT1 papillary thyroid carcinoma: a retrospective study of associations with clinicopathological parameters in 226 fine-needle aspirates.

Authors:  Yanli Zhu; Wenhao Ren; Yuntao Song; Zhihui Fan; Qian Wang; Haizhu Jin; Yiyi Guo; Yanhua Bai
Journal:  Gland Surg       Date:  2021-01

Review 3.  Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.

Authors:  Jinwei Hu; Isabella J Yuan; Saied Mirshahidi; Alfred Simental; Steve C Lee; Xiangpeng Yuan
Journal:  Int J Mol Sci       Date:  2021-02-16       Impact factor: 5.923

4.  Overexpression of novel long intergenic non‑coding RNA LINC02454 is associated with a poor prognosis in papillary thyroid cancer.

Authors:  Juan Tan; Ling Liu; Zhihua Zuo; Bin Song; Tingting Cai; Dafa Ding; Yibing Lu; Xiaolong Ye
Journal:  Oncol Rep       Date:  2020-08-03       Impact factor: 3.906

5.  CircRNA_104565 Promoted Cell Proliferation in Papillary Thyroid Carcinoma by Sponging miR-134.

Authors:  Jianming Gong; Xiangdong Kong; Jinhui Qi; Jiangkun Lu; Shaofeng Yuan; Ming Wu
Journal:  Int J Gen Med       Date:  2021-01-18

6.  Comparison of Korean vs. American Thyroid Imaging Reporting and Data System in Malignancy Risk Assessment of Indeterminate Thyroid Nodules.

Authors:  Sunyoung Kang; Seul Ki Kwon; Hoon Sung Choi; Min Joo Kim; Young Joo Park; Do Joon Park; Sun Wook Cho
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-21

7.  Diffuse sclerosing variant of papillary thyroid carcinoma: outcomes of 33 cases.

Authors:  Daniela Cavaco; Ana Filipa Martins; Rafael Cabrera; Helena Vilar; Valeriano Leite
Journal:  Eur Thyroid J       Date:  2022-01-19

Review 8.  Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis.

Authors:  Lane B Donaldson; Flora Yan; Patrick F Morgan; John M Kaczmar; Jyotika K Fernandes; Shaun A Nguyen; Rachel L Jester; Terry A Day
Journal:  Endocrine       Date:  2020-10-06       Impact factor: 3.633

9.  Diagnostic Efficacy of Ultrasound, Cytology, and BRAFV600E Mutation Analysis and Their Combined Use in Thyroid Nodule Screening for Papillary Thyroid Microcarcinoma.

Authors:  Jing Du; Ruijun Han; Cui Chen; Xiaowei Ma; Yuling Shen; Jun Chen; Fenghua Li
Journal:  Front Oncol       Date:  2022-01-03       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.